A comment on 'Glucagon-like peptide-1 receptor agonists and risk of thyroid cancer: A systematic review and meta-analysis of randomized controlled trials'

被引：0
|
作者：
Goldenberg, Ronald M. [1 ,2 ]
机构：
[1] LMC Diabet & Endocrinol, Vaughan, ON, Canada
[2] LMC Diabet & Endocrinol, 1600 Steeles Ave West 5, Vaughan, ON L4K 4M2, Canada
来源：
DIABETES OBESITY & METABOLISM | 2024年 / 26卷 / 07期
关键词：
D O I：
10.1111/dom.15588
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2997 / 2999
页数：3
相关论文
共 50 条
  • [1] Glucagon-like peptide-1 receptor agonists and risk of thyroid cancer: A systematic review and meta-analysis of randomized controlled trials
    Silverii, Giovanni Antonio
    Monami, Matteo
    Gallo, Marco
    Ragni, Alberto
    Prattichizzo, Francesco
    Renzelli, Valerio
    Ceriello, Antonio
    Mannucci, Edoardo
    DIABETES OBESITY & METABOLISM, 2024, 26 (03): : 891 - 900
  • [2] Glucagon-like peptide-1 receptor agonists and risk of gastrointestinal cancers: A systematic review and meta-analysis of randomized controlled trials
    Figlioli, Gisella
    Piovani, Daniele
    Peppas, Spyros
    Pugliese, Nicola
    Hassan, Cesare
    Repici, Alessandro
    Lleo, Ana
    Aghemo, Alessio
    Bonovas, Stefanos
    PHARMACOLOGICAL RESEARCH, 2024, 208
  • [3] Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials
    Monami, Matteo
    Dicembrini, Ilaria
    Nreu, Besmir
    Andreozzi, Francesco
    Sesti, Giorgio
    Mannucci, Edoardo
    ACTA DIABETOLOGICA, 2017, 54 (12) : 1101 - 1114
  • [4] Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials
    Matteo Monami
    Ilaria Dicembrini
    Besmir Nreu
    Francesco Andreozzi
    Giorgio Sesti
    Edoardo Mannucci
    Acta Diabetologica, 2017, 54 : 1101 - 1114
  • [5] Efficacy and safety of glucagon-like peptide-1 receptor agonists on prediabetes: a systematic review and meta-analysis of randomized controlled trials
    Salamah, Hazem Mohamed
    Marey, Ahmed
    Abugdida, Mohamed
    Abualkhair, Khaled Alsayed
    Elshenawy, Salem
    Elhassan, Wael Atif Fadl
    Naguib, Mostafa Mahmoud
    Malnev, Dmitrii
    Durrani, Jamrose
    Bailey, Ronelle
    Tsyunchyk, Anastasiia
    Ibrahim, Lena
    Zavgorodneva, Zhanna
    Sherazi, Andleeb
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [6] Glucagon-like peptide-1 receptor agonists and mental health: A meta-analysis of randomized controlled trials
    Silverii, Giovanni Antonio
    Marinelli, Christian
    Mannucci, Edoardo
    Rotella, Francesco
    DIABETES OBESITY & METABOLISM, 2024, 26 (06): : 2505 - 2508
  • [7] Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials
    M. Monami
    B. Nreu
    A. Scatena
    S. Giannini
    F. Andreozzi
    G. Sesti
    E. Mannucci
    Journal of Endocrinological Investigation, 2017, 40 : 1251 - 1258
  • [8] Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials
    Monami, M.
    Nreu, B.
    Scatena, A.
    Giannini, S.
    Andreozzi, F.
    Sesti, G.
    Mannucci, E.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2017, 40 (11) : 1251 - 1258
  • [9] Effect of glucagon-like peptide-1 receptor agonists on renal function: A meta-analysis of randomized controlled trials
    Simental-Mendia, Mario
    Linden-Torres, Enrique
    Sanchez-Garcia, Adriana
    Sahebkar, Amirhossein
    Simental-Mendia, Luis E.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (08) : 3566 - 3576
  • [10] Impact of glucagon-like peptide-1 receptor agonists on adiponectin concentrations: A meta-analysis of randomized controlled trials
    Simental-Mendia, Luis E.
    Sanchez-Garcia, Adriana
    Linden-Torres, Enrique
    Simental-Mendia, Mario
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (11) : 4140 - 4149
12345